Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1864 1
1869 1
1873 1
1874 1
1875 1
1877 1
1879 1
1882 1
1886 1
1890 1
1897 2
1902 2
1904 1
1908 2
1909 1
1910 1
1911 2
1912 5
1913 3
1914 6
1915 2
1918 1
1919 2
1920 2
1921 1
1923 1
1924 1
1925 2
1926 1
1930 7
1931 3
1932 6
1934 5
1935 4
1936 2
1937 1
1938 1
1940 1
1942 2
1943 1
1944 2
1945 15
1946 39
1947 28
1948 19
1949 20
1950 36
1951 31
1952 44
1953 45
1954 44
1955 30
1956 34
1957 37
1958 40
1959 39
1960 48
1961 65
1962 38
1963 122
1964 137
1965 101
1966 116
1967 100
1968 133
1969 120
1970 145
1971 159
1972 141
1973 150
1974 130
1975 120
1976 123
1977 143
1978 152
1979 199
1980 182
1981 197
1982 208
1983 213
1984 286
1985 276
1986 263
1987 317
1988 289
1989 302
1990 339
1991 322
1992 288
1993 340
1994 327
1995 351
1996 344
1997 345
1998 383
1999 444
2000 421
2001 478
2002 502
2003 513
2004 494
2005 486
2006 506
2007 537
2008 569
2009 557
2010 664
2011 670
2012 800
2013 913
2014 863
2015 917
2016 940
2017 1057
2018 1189
2019 1255
2020 1393
2021 102
Text availability
Article attribute
Article type
Publication date

Search Results

23,261 results
Results by year
Filters applied: . Clear all
Page 1
Hair Loss: Common Causes and Treatment.
Phillips TG, Slomiany WP, Allison R. Phillips TG, et al. Am Fam Physician. 2017 Sep 15;96(6):371-378. Am Fam Physician. 2017. PMID: 28925637 Free article.
Patients may present to their family physician first with diffuse or patchy hair loss. Scarring alopecia is best evaluated by a dermatologist. Nonscarring alopecias can be readily diagnosed and treated in the family physician's office. Androgenetic alopecia c …
Patients may present to their family physician first with diffuse or patchy hair loss. Scarring alopecia is best evaluated by a derma …
Histopathology of alopecia: a clinicopathological approach to diagnosis.
Stefanato CM. Stefanato CM. Histopathology. 2010 Jan;56(1):24-38. doi: 10.1111/j.1365-2559.2009.03439.x. Histopathology. 2010. PMID: 20055903 Review.
Interpretation of the histopathological findings of primary scarring and non-scarring alopecias may prove daunting. This is especially true if the biopsy specimen is inadequate, and the clinical history and pattern of the alopecia are not known. ...The non-scarring …
Interpretation of the histopathological findings of primary scarring and non-scarring alopecias may prove daunting. This is especiall …
Off-Label Use of Topical Minoxidil in Alopecia: A Review.
Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S. Stoehr JR, et al. Am J Clin Dermatol. 2019 Apr;20(2):237-250. doi: 10.1007/s40257-018-0409-y. Am J Clin Dermatol. 2019. PMID: 30604379 Review.
Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. It was approved by the United States Food and Drug Administration for the treatment of androgenetic alopecia in 1988. Since its approval, minoxidil ha …
Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. It was approved b …
New drugs under investigation for the treatment of alopecias.
Ocampo-Garza J, Griggs J, Tosti A. Ocampo-Garza J, et al. Expert Opin Investig Drugs. 2019 Mar;28(3):275-284. doi: 10.1080/13543784.2019.1568989. Epub 2019 Jan 22. Expert Opin Investig Drugs. 2019. PMID: 30642204 Review.
AREAS COVERED: This paper reviews the new and emerging treatments for two of the most common forms of alopecia, known as androgenetic alopecia and alopecia areata. A literature search of PubMed/MEDLINE and ClinicalTrial.gov was performed to gather information …
AREAS COVERED: This paper reviews the new and emerging treatments for two of the most common forms of alopecia, known as androgenetic …
Cicatricial alopecia.
Kanti V, Röwert-Huber J, Vogt A, Blume-Peytavi U. Kanti V, et al. J Dtsch Dermatol Ges. 2018 Apr;16(4):435-461. doi: 10.1111/ddg.13498. J Dtsch Dermatol Ges. 2018. PMID: 29645394 Review.
The diagnosis is often delayed. While most forms of cicatricial alopecia can be clearly diagnosed based on clinical presentation in the acute disease stage, diagnosis can be challenging in the subacute, early or late disease stages. ...In clinically unclear cases, a biopsy …
The diagnosis is often delayed. While most forms of cicatricial alopecia can be clearly diagnosed based on clinical presentation in t …
The Diagnosis and Treatment of Hair and Scalp Diseases.
Wolff H, Fischer TW, Blume-Peytavi U. Wolff H, et al. Dtsch Arztebl Int. 2016 May 27;113(21):377-86. doi: 10.3238/arztebl.2016.0377. Dtsch Arztebl Int. 2016. PMID: 27504707 Free PMC article. Review.
Alopecia areata is patchy hair loss arising over a short time and involving the scalp, eyebrows, beard, or entire body. The hair loss of alopecia areata is reversible in principle but hard to treat. Folliculitis decalvans is a form of alopecia with scarring,
Alopecia areata is patchy hair loss arising over a short time and involving the scalp, eyebrows, beard, or entire body. The hair loss
Female Androgenetic Alopecia: An Update on Diagnosis and Management.
Starace M, Orlando G, Alessandrini A, Piraccini BM. Starace M, et al. Am J Clin Dermatol. 2020 Feb;21(1):69-84. doi: 10.1007/s40257-019-00479-x. Am J Clin Dermatol. 2020. PMID: 31677111 Review.
Female androgenetic alopecia (FAGA) is a common cause of non-scarring alopecia in women. ...A scalp biopsy can be useful when the clinical evaluation does not provide a definitive diagnosis or when cicatricial alopecias with hair loss in the distribution of F …
Female androgenetic alopecia (FAGA) is a common cause of non-scarring alopecia in women. ...A scalp biopsy can be useful when …
A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. Lee SW, et al. J Drugs Dermatol. 2018 Apr 1;17(4):457-463. J Drugs Dermatol. 2018. PMID: 29601622 Free PMC article. Review.
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of androgenetic alopecia. Although FNS is efficacious for hair regrowth, its sy …
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administration (FDA) and …
Pathomechanisms of immune-mediated alopecia.
Anzai A, Wang EHC, Lee EY, Aoki V, Christiano AM. Anzai A, et al. Int Immunol. 2019 Jul 13;31(7):439-447. doi: 10.1093/intimm/dxz039. Int Immunol. 2019. PMID: 31050755 Free PMC article. Review.
When this IP collapses, inflammatory infiltrates that aggregate around the bulge and bulb launch an immune attack on the HF, resulting in hair loss or alopecia. Alopecia areata (AA) and primary cicatricial alopecia (PCA) are two common forms of immune-mediate …
When this IP collapses, inflammatory infiltrates that aggregate around the bulge and bulb launch an immune attack on the HF, resulting in ha …
Safety concerns when using novel medications to treat alopecia.
Almohanna HM, Perper M, Tosti A. Almohanna HM, et al. Expert Opin Drug Saf. 2018 Nov;17(11):1115-1128. doi: 10.1080/14740338.2018.1533549. Epub 2018 Oct 25. Expert Opin Drug Saf. 2018. PMID: 30318935 Review.
Alopecia is often a cause of great concern to patients for cosmetic and psychologic reasons. The aim of treating non-scarring alopecias is to reduce hair loss and, to some extent, enhance hair regrowth. ...
Alopecia is often a cause of great concern to patients for cosmetic and psychologic reasons. The aim of treating non-scarring alop
23,261 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback